Dr. Bronner’s Sponsors MAPS Psychedelic Science Conference in Denver, Colorado from June 19–23, 2023
Dr. Bronner’s to Distribute Free Limited Edition “Heal Soul!” Soaps; Host ‘Deep Space’, an Interactive Art Lounge; and Company CEO David Bronner to Speak at Conference
June 12, 2023
VISTA, CA – Dr. Bronner’s, family-owned maker of the top-selling natural brand of soap in North America, is a Founding Sponsor of MAPS Psychedelic Science Conference occurring June 19-23, 2023, in Denver, Colorado at the Colorado Convention Center. According to organizers, the conference is expected to be the largest and most influential psychedelic conference in history, with an estimated 10,000 people registered to attend. David Bronner, Cosmic Engagement Officer (CEO) of Dr. Bronner’s and board member of MAPS, is scheduled to speak at the conference; and Dr. Bronner’s is the sponsor of Deep Space, an interactive art zone and lounge where attendees can engage in yoga and movement, music, dancing, exercises to promote social-connection, storytelling, and much more. The company has also produced a limited-edition “Heal Soul!” label for its 4oz. Pure-Castile Liquid Soap, which will be provided freely to conference attendees. To view the “Heal Soul!” label and its message, go to: https://bit.ly/3oRK2xn.
The Psychedelic Science Conference is a biennial event organized by the Multidisciplinary Association for Psychedelic Studies (MAPS), and features presentations by leading researchers and advocates in the field of psychedelics, covering a wide range of related topics, as well as the ethical, legal, and cultural implications of their research and use. The conference has been held every two years since 2013. MAPS is a nonprofit organization founded in 1986 that is dedicated to changing the way people think of, talk about, and consume psychedelics, through research, education, and advocacy. To learn more about MAPS, go to: https://maps.org.
“We support the work of MAPS and many other organizations that are bringing psychedelic medicines and healing to the world,” said David Bronner, Cosmic Engagement Officer of Dr. Bronner’s. “The promise of psychedelics to heal and open hearts and minds, and address PTSD, depression, addiction, and a host of other mental health challenges, is enormous. We’re sponsoring the Psychedelic Science Conference to promote critical education and discussions, as well as to advance discourse around ethics and conservation related to Indigenous rights and traditional plant medicines.”
Dr. Bronner’s Events at Psychedelic Science 2023
The Unified Field Theory of Psychedelic Advocacy
Wednesday, June 21 | Please See Conference Schedule for Time
Policy Stage at Psychedelic Science Conference, Colorado Convention Center
David Bronner, Cosmic Engagement Officer of Dr. Bronner’s, will review pathways and policy strategies for integrating psychedelic medicines and therapies into U.S. society. This talk will discuss pros and cons of regulated access vs. self-regulating communities and churches in the context of decriminalization; and examine which populations are served, and broader questions of equitable access, as well as impacts on Indigenous sources of medicine.
Deep Space: Experiential Art Zone
Wednesday, June 21 – Friday, June 23 | 10 am to 7 pm
Psychedelic Science Conference, Colorado Convention Center
Deep Space is an interactive art zone and lounge where attendees can engage in yoga and movement, music, dancing, exercises to promote social-connection, storytelling, and much more. Deep Space aims to provide a respite from main stage conference sessions. Free samples of Dr. Bronner’s Magic All-One Chocolate and 4oz. “Heal Soul!” soaps will also be available to conference attendees in the Deep Space zone.
Thursday, June 22 | 7 pm to 8 pm
Ietef Vita aka DJ Cavem, eco-hip hop artist and activist educator will perform a live DJ set. Dr. Bronner’s partnership with DJ Cavem is rooted in the company’s commitment to promoting regenerative organic agriculture and plant-based solutions to climate crisis and factory farming. DJ Cavem is a community leader who is advancing plant-based, regenerative organic food sovereignty work.
A longtime advocate of drug policy reform and psychedelic-assisted therapy, Dr. Bronner’s has given more than $20 million over the last three years to organizations in support of psychedelic-assisted therapy and plant medicine initiatives. In 2022, Dr. Bronner’s funded more than 70 organizations working in drug policy reform and related advocacy, including Chacruna Institute, Drug Policy Alliance, Fireside Project, Heroic Hearts Project, Indigenous Peyote Conservation Initiative, International Center for Ethnobotanical Education Research & Service, The Ancestor Project, Sacred Garden Community Church, Sacred Plant Alliance, Society for Psychedelic Outreach Reform and Education, Spearitwurx, Students for Sensible Drug Policy, Veterans Exploring Treatment Solutions, and many others. The company is a major supporter of MAPS, and its efforts to gain Food and Drug Administration (FDA) approval for MDMA-assisted therapy. Dr. Bronner’s gave $1 million to MAPS in 2022 and has contributed more than $6.7 million to MAPS over the past 16 years. David Bronner has been a board member of MAPS since 2015.
Dr. Bronner’s, RiverStyx Foundation and other like-minded seed funders helped launch the Indigenous Medicine Conservation Fund (IMC Fund) in 2022, to strengthen Indigenous communities’ efforts to preserve traditional psychedelic plant medicines which are threatened by land-theft and destruction, climate change, commercialization, overharvesting, and cultural appropriation. This year’s Psychedelic Science Conference will have a Plant Medicine Track, and the Indigenous-led nonprofit IMC Fund will present on several conference panels. In the one year since its launch, IMC Fund has raised more than $10 million to support 22 Indigenous-led conservation projects in Brazil, Colombia, Gabon, Mexico, and Peru. To learn more about IMC Fund, go to: https://www.imc.fund.
Dr. Bronner’s All-One! Report, the company’s annual sustainability and impact report, provides further information about the company’s philanthropic support of drug policy reform, psychedelic-assisted therapy, and other plant medicine related initiatives. To learn more, see: https://info.drbronner.com/media-center/all-one-reports/.
About Dr. Bronner’s
Founded in the U.S. in 1948, Dr. Bronner’s is the top-selling natural brand of soap in North America and a leading brand worldwide. The company is an independent, family-owned business based in California, committed to honoring the vision of founder Emanuel Bronner by making socially and environmentally responsible personal care and food products of the highest quality, and by dedicating profits to help make a better world. Dr. Bronner’s commitment to social justice, environmental sustainability, and progressive business practices is part of the company’s mission to put into practice the “All-One” philosophy printed on the company’s iconic soap labels. The company caps executive salaries at 5 times its lowest paid fully vested position and donates all profits not needed for business development. Dr. Bronner’s generated approximately $169 million in revenue in 2022 and gave an estimated $8.5 million to fund charity and activism. In 2022, a bottle or bar of Dr. Bronner’s Pure-Castile Soap was sold, on average, every 0.95 seconds. 2023 marks the 75th anniversary of the company. To learn more, please visit: https://drbronner.com/.